Selected Presentations & Appearances
Clinical cases “beyond the guidelines” - The American experience.
- New Horizons In Heart Failure.
· June 3, 2022
- June 4, 2022
International Meeting or Conference
Microport CRM,
Prague, Czech Republic
Atrial Fibrillation Ablation: State of the Art in 2020.
- Irwin R. Callen, MD Memorial Lecture
· August 19, 2020
Keynote/Named Lecture
Florida Chapter, American College of Cardiology,
Ablation, ICDs, and CRT for Heart Failure.
- The 6th Annual Yale Comprehensive Heart Failure Symposium
· October 4, 2019
Instructional Course, Workshop, or Symposium
Improving Outcomes for Patients with AF and HF: Focusing on Access to Care and Treatment Adherence
· May 12, 2018
National Scientific Meeting
Heart Rhythm Society,
Optimizing Outcomes in CRT: Patient Selection and Device Implantation
- Duke Cardiology Grand Rounds
· May 23, 2017
Interview
Pacemakers, Defibrillators, and Catheter Ablation: An essential overview of common electrophysiology procedures
- Duke Clinical Research Institute Clinical Education Series
· September 6, 2016
Lecture
Service to the Profession
Member
- LAAO Risk Model Work Group
·
April 2021
Committee Service
NCDR,
Data and Safety Monitoring Board
- Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure (PROMPT-HF)
·
2021
Committee Service
Editorial Board Member
·
2021
Editorial Activities
American Heart Journal ,
Ad Hoc Reviewer
·
2019
Editorial Activities
Journal of Interventional Cardiac Electrophysiology,
Ad Hoc Reviewer
·
2019
Editorial Activities
Journal of the American College of Cardiology,
Member
·
2017
Other
American Heart Association,
Clinical Event Classification Reviewer
·
2017
- 2017
Committee Service
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure (GENETIC-AF),
Ad Hoc Reviewer
·
2016
Editorial Activities
American Journal of Cardiology,
Clinical Event Classification Reviewer
·
2016
- 2018
Committee Service
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus (HARMONY Outcomes) ,
Clinical Event Classification Reviewer
·
2015
- 2017
Committee Service
Myelodysplastic Syndrome Event Free Survival with Iron Chelation Therapy Study (TELESTO),
Ad Hoc Reviewer
·
2015
Editorial Activities
Journal of the American Heart Association,
Member
·
2015
Other
Heart Rhythm Society,
Ad Hoc Reviewer
·
2015
Editorial Activities
JACC: Clinical Electrophysiology,
Clinical Event Classification Reviewer
·
2015
- 2016
Committee Service
Examining Use of tiCagreLor In paD (EUCLID) ,
Ad Hoc Reviewer
·
2014
Editorial Activities
Circulation,
Member
·
2013
Other
American College of Cardiology,
Ad Hoc Reviewer
- American Heart Journal
·
2013
Editorial Activities
Academic & Administrative Activities
Duke University Cardiovascular Cooperative Society Board Member, Fellow Liaison, 2015-2017
Internship Selection Committee, Massachusetts General Hospital Internal Medicine Residency Program, 2010-2013
Weill Cornell Medical College Alumni Association, Student Representative, 2006-2010
Clinical Activities
Approximately 80% of my professional effort is devoted to the invasive and non-invasive management of arrhythmias in the inpatient and outpatient setting. My clinical interests include complex ablation of atrial and ventricular arrhythmias, supraventricular tachycardia, atrial fibrillation, cardiac resynchronization therapy, conduction system pacing, and left atrial appendage occlusion.